Development of phenylpropanoid sucrose esters as antidiabetic lead compounds
Alpha-glucosidase inhibitors (AGIs), particularly Acarbose, have received increased attention in the treatment of Type 2 diabetes (T2D) due to their effectiveness in managing postprandial blood glucose and associated macrovascular and microvascular health complications. However, AGIs are commonly pl...
محفوظ في:
المؤلف الرئيسي: | Ong, Li Lin |
---|---|
مؤلفون آخرون: | Zaher Judeh |
التنسيق: | Theses and Dissertations |
اللغة: | English |
منشور في: |
2019
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://hdl.handle.net/10356/106085 http://hdl.handle.net/10220/47906 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
المؤسسة: | Nanyang Technological University |
اللغة: | English |
مواد مشابهة
-
Investigation of phenylpropanoid sucrose esters as antidiabetic compounds
بواسطة: Wong, Kathy Pooi Wen
منشور في: (2020) -
Development of phenylpropanoid sucrose esters (PSEs) as lead drug candidates for alpha glucosidase inhibition
بواسطة: Devaraj, Surabhi
منشور في: (2017) -
Synthesis and anticancer activity of phenylpropanoid sucrose esters
بواسطة: Parthasarathi Panda
منشور في: (2015) -
An orthogonal approach for the precise synthesis of phenylpropanoid sucrose esters
بواسطة: Ong, Li Lin, وآخرون
منشور في: (2022) -
Targeted synthesis of 3,3'-, 3,4'- and 3,6'-phenylpropanoid sucrose esters
بواسطة: Wong, Kathy Pooi Wen, وآخرون
منشور في: (2022)